Erratum

Erratum to: Incidence of asymptomatic oesophageal lesions after atrial fibrillation ablation using an oesophageal temperature probe with insulated thermocouples: a comparative controlled study [Europace 2017;19:385 –91]
Source: Europace - Category: Cardiology Source Type: research

Related Links:

Eko has won FDA clearance for a suite of algorithms that will allow its digital stethoscope to more accurately screen for heart conditions that include heart murmurs and atrial fibrillation (AFib) during routine physical exams. The San Francisco, CA-based company Eko’s AI identifies heart murmurs with 87% sensitivity and 87% specificity. The company said in comparison, a recent study revealed that using traditional stethoscopes, primary care physicians had a sensitivity of 43% and a specificity of 69% for detecting significant valvular heart disease, which affects more than five million Americans. The AI ...
Source: MDDI - Category: Medical Devices Authors: Tags: Cardiovascular Digital Health Source Type: news
AbstractBackground and aimAtrial fibrillation (AF), the most common sustained arrhythmia in older adults, causes significant complications such as stroke, dementia, and decreased quality of life. Frailty is a geriatric syndrome that is associated with increased risk of poor clinical outcomes including falls, disability, and mortality. We aimed to investigate the relationship between AF and frailty and functionality in older adults.MethodsA total of 123 patients 64 with AF and 59 with normal sinus rhythm were enrolled in the study with cross-sectional design. All patients underwent comprehensive geriatric assessment (CGA). ...
Source: Irish Journal of Medical Science - Category: General Medicine Source Type: research
Berkeley health-tech startup Eko was granted FDA clearance today to take its algorithm for detecting atrial fibrillation to the market.   The algorithm, in tandem with a digital stethoscope, is meant to be used to screen for atrial fibrillation and other types of heart disease caused by heart murmurs — a condition that can result in a stroke or heart failure if left untreated. Connor Landgraf, CEO and co-founder of Eko, said it is the first in-office screening algorithm used with a stethoscope…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
Eko, a maker of high-end digital stethoscopes, has just received the first FDA clearance for its devices to use AI algorithms to automatically detect atrial fibrillation (AFib) and heart murmurs. Using this capability, primary care physicians, who ar...
Source: Medgadget - Category: Medical Devices Authors: Tags: Anesthesiology Cardiology Pediatrics Source Type: blogs
Condition:   Persistent Atrial Fibrillation Intervention:   Device: TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) Sponsor:   Abbott Medical Devices Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Authors: Akdemir B, Roukoz H Abstract Background: The most common conduction abnormality after transcatheter aortic valve replacement (TAVR) is new-onset left bundle branch block (LBBB) with an exact frequency that varies based on the valve system used for TAVR. PPM implantation in patients with persistent new onset LBBB post TAVR is controversial. The primary objective of this study is to report PPM utilisation and mortality in this patient population.Methods: A TAVR registry included patients older than 18 years who underwent TAVR between March 2012 and June 2015 at University of Minnesota Medical Centre. ...
Source: Acta Cardiologica - Category: Cardiology Tags: Acta Cardiol Source Type: research
There are new developments surrounding Verily Life Science’s prescription-only smartwatch. FDA has granted a new clearance for the South San Francisco-based company’s Study Watch to measure irregular heartbeats. The clearance comes one year after Verily received its first 510(k) clearance for ECG for the wrist-worn, sensor-based device. Verily announced in September of 2019 that it collaborated with iRhythm to develop solutions aimed at the Study Watch to improve the screening, diagnosis, and management of patients with atrial fibrillation (AFib). The collaboration brings together iRhyth...
Source: MDDI - Category: Medical Devices Authors: Tags: Regulatory and Compliance Digital Health Source Type: news
Studies have shown an increased prevalence of AF among athletes. Are usual AF treatments equally efficacious in athletes and non-athletes? How does continued exercise training influence outcome?Europace
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
ABSTRACTBackgroundAtrial fibrillation (AF) is associated with heart failure (HF) rehospitalization in patients with heart failure with preserved ejection fraction (HFpEF).ObjectiveWe tested the hypothesis that catheter ablation of AF could reduce HF rehospitalization compared with conventional pharmacotherapy in patients with HFpEF.MethodsEighty ‐five consecutive HFpEF (EF≥50% and a history of HF hospitalization) patients diagnosed as AF by 12‐lead electrocardiogram were retrospectively analyzed. Thirty‐five patients who received catheter ablation (ABL group) were compared with 50 patients treated by anti‐arrhyt...
Source: Journal of Cardiovascular Electrophysiology - Category: Cardiology Authors: Tags: ORIGINAL ARTICLE Source Type: research
Conclusions: Dapagliflozin decreased the incidence of reported episodes of AF/AFL adverse events in high-risk patients with T2DM. This effect was consistent regardless of the patients' prior history of AF, ASCVD, or HF. Clinical Trial Registration: URL: https://clinicaltrials.gov Unique Identifier: NCT01730534. PMID: 31983236 [PubMed - as supplied by publisher]
Source: Circulation - Category: Cardiology Authors: Tags: Circulation Source Type: research
More News: Atrial Fibrillation | Study